In this report, the
United States Transdermal Skin Patch Market 2017 is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Transdermal Skin Patch in these regions, from 2012 to 2022 (forecast).
United States Transdermal Skin Patch market competition by top manufacturers/players, with Transdermal Skin Patch sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Luye Pharma Group Ltd.
Purdue Pharma L.P.
Teva Pharmaceutical Industries Ltd.
Request more information at http://globalqyresearch.com/download-sample/232667 On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Fentanyl Transdermal Skin Patch
Nicotine Transdermal Skin Patch
Clonidine Transdermal Skin Patch
Buprenorphine Transdermal Skin Patch
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Transdermal Skin Patch for each application, including
Relieve Severe Pain
Stop Smoking Cigarettes
Treat An Overactive Bladder
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
View full report at http://globalqyresearch.com/united-states-transdermal-skin-patch-market-report-2017
Table of ContentsUnited States Transdermal Skin Patch Market Report 2017
1 Transdermal Skin Patch Overview
1.1 Product Overview and Scope of Transdermal Skin Patch
1.2 Classification of Transdermal Skin Patch by Product Category
1.2.1 United States Transdermal Skin Patch Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Transdermal Skin Patch Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Fentanyl Transdermal Skin Patch
1.2.4 Nicotine Transdermal Skin Patch
1.2.5 Clonidine Transdermal Skin Patch
1.2.6 Buprenorphine Transdermal Skin Patch
1.3 United States Transdermal Skin Patch Market by Application/End Users
1.3.1 United States Transdermal Skin Patch Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Relieve Severe Pain
1.3.3 Stop Smoking Cigarettes
1.3.4 Treat An Overactive Bladder
1.3.5 Others
1.4 United States Transdermal Skin Patch Market by Region
1.4.1 United States Transdermal Skin Patch Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Transdermal Skin Patch Status and Prospect (2012-2022)
1.4.3 Southwest Transdermal Skin Patch Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Transdermal Skin Patch Status and Prospect (2012-2022)
1.4.5 New England Transdermal Skin Patch Status and Prospect (2012-2022)
1.4.6 The South Transdermal Skin Patch Status and Prospect (2012-2022)
1.4.7 The Midwest Transdermal Skin Patch Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Transdermal Skin Patch (2012-2022)
1.5.1 United States Transdermal Skin Patch Sales and Growth Rate (2012-2022)
1.5.2 United States Transdermal Skin Patch Revenue and Growth Rate (2012-2022)
2 United States Transdermal Skin Patch Market Competition by Players/Suppliers
2.1 United States Transdermal Skin Patch Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Transdermal Skin Patch Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Transdermal Skin Patch Average Price by Players/Suppliers (2012-2017)
2.4 United States Transdermal Skin Patch Market Competitive Situation and Trends
2.4.1 United States Transdermal Skin Patch Market Concentration Rate
2.4.2 United States Transdermal Skin Patch Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Transdermal Skin Patch Manufacturing Base Distribution, Sales Area, Product Type
3 United States Transdermal Skin Patch Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Transdermal Skin Patch Sales and Market Share by Region (2012-2017)
3.2 United States Transdermal Skin Patch Revenue and Market Share by Region (2012-2017)
3.3 United States Transdermal Skin Patch Price by Region (2012-2017)
4 United States Transdermal Skin Patch Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Transdermal Skin Patch Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Transdermal Skin Patch Revenue and Market Share by Type (2012-2017)
4.3 United States Transdermal Skin Patch Price by Type (2012-2017)
4.4 United States Transdermal Skin Patch Sales Growth Rate by Type (2012-2017)
5 United States Transdermal Skin Patch Sales (Volume) by Application (2012-2017)
5.1 United States Transdermal Skin Patch Sales and Market Share by Application (2012-2017)
5.2 United States Transdermal Skin Patch Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Transdermal Skin Patch Players/Suppliers Profiles and Sales Data
6.1 Hisamitsu Pharmaceutical
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Transdermal Skin Patch Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Novartis
6.2.2 Transdermal Skin Patch Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novartis Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Johnson & Johnson
6.3.2 Transdermal Skin Patch Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Johnson & Johnson Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Teikoku Pharma
6.4.2 Transdermal Skin Patch Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Teikoku Pharma Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Mylan
6.5.2 Transdermal Skin Patch Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Mylan Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Actavis
6.6.2 Transdermal Skin Patch Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Actavis Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Mundipharma
6.7.2 Transdermal Skin Patch Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Mundipharma Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Henan Lingrui Pharmaceutical
6.8.2 Transdermal Skin Patch Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Changzhou Siyao
6.9.2 Transdermal Skin Patch Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Changzhou Siyao Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Rfl Pharmaceutical
6.10.2 Transdermal Skin Patch Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Rfl Pharmaceutical Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Luye Pharma Group Ltd.
6.12 Purdue Pharma L.P.
6.13 Teva Pharmaceutical Industries Ltd.
7 Transdermal Skin Patch Manufacturing Cost Analysis
7.1 Transdermal Skin Patch Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Transdermal Skin Patch
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Transdermal Skin Patch Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Transdermal Skin Patch Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Transdermal Skin Patch Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Transdermal Skin Patch Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Transdermal Skin Patch Sales Volume Forecast by Type (2017-2022)
11.3 United States Transdermal Skin Patch Sales Volume Forecast by Application (2017-2022)
11.4 United States Transdermal Skin Patch Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
To Purchase this premium Report With Complete TOC at http://globalqyresearch.com/checkout-form/0/232667
About Us:
Global QYResearch (http://globalqyresearch.com/) is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.
Contact Us:Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom
Contact: +44 20 32392407Email: sales@globalqyresearch.comFollow us:https://www.linkedin.com/company/global-qy-researchTwitter: https://twitter.com/gqyresearch
Comments
Post a Comment